Literature DB >> 1389515

Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusion.

R N Scott1, R Blackie, D J Kerr, J Hughes, G Burnside, R M MacKie, D S Byrne, A J McKay.   

Abstract

Levels of melphalan (L-phenylalanine mustard) were measured in the tissues of tumour-bearing limbs treated by isolated limb perfusion (ILP). 41 samples of melanoma tissue, normal fat and skin were excised from 15 patients during ILP. A high performance liquid chromatography assay was used to measure melphalan concentrations. Levels of melphalan were higher in tumour than in fat (P < 0.01, Wilcoxon signed-ranks test), and not significantly different from levels in adjacent skin. In 2 cases there was significant regional toxicity in the treated limb, but this was not related to the levels of melphalan measured in the tissues of the limb. It is encouraging that the concentrations of melphalan which were achieved in large necrotic nodules by ILP were similar to those in well-perfused normal skin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389515     DOI: 10.1016/0959-8049(92)90009-q

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

Review 1.  Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.

Authors:  Dale Han; Georgia M Beasley; Douglas S Tyler; Jonathan S Zager
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-10-07       Impact factor: 4.481

2.  Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies.

Authors:  J F Thompson; G A Siebert; Y G Anissimov; B M Smithers; A Doubrovsky; C D Anderson; M S Roberts
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

3.  The effects of perfusion conditions on melphalan distribution in the isolated perfused rat hindlimb bearing a human melanoma xenograft.

Authors:  Z Y Wu; B M Smithers; P G Parsons; M S Roberts
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.